The UNM Shared Flow Cytometry and Chemical Biology Resource consists of laboratories located in the UNM Cancer Research Facility and The Research Incubator Building (RIB), 5 minutes walking distance The Cytometry and Screening components are directed by Bruce Edwards, Ph.D., and operated by Brandy Crowder and Catherine Prudom, Ph.D. respectively. The Cytometry and Screening Lab houses flow cytometers and other equipment that are available for use by researchers in the Cancer Center. The Resource developed the capability for high throughput screening with flow cytometers which has evolved into a full-fledged High Throughput Screening operation called the UNM Center for Molecular Discovery which is part of the NIH Roadmap funded Molecular Libraries Probe Production Center Network. Co-Director Tudor Oprea leads collaborative efforts in computational and informatics approaches to small molecule discovery housed in RIB. During the reporting period. Cancer Center members published >70 articles in association with resource usage including those based on computational approaches alone. Twenty-six members representing all 4 Cancer Center research programs used resource services (80% of total use) in conjunction with 25 research grants. Current charge backs to resource users are in the low to mid-range of nation-wide rates and Cancer Center members qualify for 20% co-pay on all rates. Resource users are individually trained in instrument and software use. New users are enabled to perform pilot projects through a waiver of use charges during the assay development phase. The Resource provides cell analysis, cell sorting, and offline data analysis as standard services. It recently introduced high throughput screening and cheminformatics, allowing resource users routine access to novel HyperCyt technology invented and developed at UNM by Bruce Edwards and Larry Sklar, the Cancer Center Associate Director of Basic Research. The overall goals of the facility are to provide: a) support services to research faculty; b) training such as ad hoc work with individual researchers and scheduled workshops in specialized areas; c) collaboration with Cancer Center investigators and trainees, particularly in the development of new research applications in small molecule identification, d) innovation through the development of high throughput capabilities and applications for use of 384 and 1536 well plates, screening of compound libraries, implementation of multiplexed bead-based analysis, and cheminformatics support for chemical biology projects; as well as e) dissemination through facility tours, descriptive poster displays, an annual open house and periodic updating of the Resource web site.

Public Health Relevance

This proposal requests support for the University of New Mexico Shared Flow Cytometry and Chemical Biology Resource. The Resource provides Cancer Center research programs with access to both conventional and advanced flow cytometry services and instruments at hourly rates in the mid to low end of rates charged by other core facilities across the country. Cancer Center researchers benefit from a range of new small molecule discoverv technoloqies and techniques invented and developed bv Resource personnel.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA118100-08
Application #
8379125
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
8
Fiscal Year
2012
Total Cost
$72,133
Indirect Cost
Name
University of New Mexico Health Sciences Center
Department
Type
DUNS #
829868723
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Kumar, Suresh; Jain, Ashish; Farzam, Farzin et al. (2018) Mechanism of Stx17 recruitment to autophagosomes via IRGM and mammalian Atg8 proteins. J Cell Biol 217:997-1013
Vicuña, Belinda; Delaney, Harold D; Flores, Kristina G et al. (2018) Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative families. J Community Genet 9:81-92
Feng, Bing; Hoskins, William; Zhang, Yan et al. (2018) Bi-stream CNN Down Syndrome screening model based on genotyping array. BMC Med Genomics 11:105
Phinney, Brandon B; Ray, Anita L; Peretti, Amanda S et al. (2018) MK2 Regulates Macrophage Chemokine Activity and Recruitment to Promote Colon Tumor Growth. Front Immunol 9:1857
Kuehl, Philip J; Grimes, Marcie J; Dubose, Devon et al. (2018) Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model. Drug Deliv 25:1127-1136
Köbel, Martin; Luo, Li; Grevers, Xin et al. (2018) Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions. Int J Gynecol Pathol :
Bredemeyer, Andrea L; Edwards, Bruce S; Haynes, Mark K et al. (2018) High-Throughput Screening Approach for Identifying Compounds That Inhibit Nonhomologous End Joining. SLAS Discov 23:624-633
Orlow, Irene; Shi, Yang; Kanetsky, Peter A et al. (2018) The interaction between vitamin D receptor polymorphisms and sun exposure around time of diagnosis influences melanoma survival. Pigment Cell Melanoma Res 31:287-296
Sharma, Geetanjali; Mauvais-Jarvis, Franck; Prossnitz, Eric R (2018) Roles of G protein-coupled estrogen receptor GPER in metabolic regulation. J Steroid Biochem Mol Biol 176:31-37
Perez, Dominique R; Edwards, Bruce S; Sklar, Larry A et al. (2018) High-Throughput Flow Cytometry Drug Combination Discovery with Novel Synergy Analysis Software, SynScreen. SLAS Discov 23:751-760

Showing the most recent 10 out of 344 publications